Lion Plans Public Offering and Enters Ag Genomics Alliance with Paradigm | GenomeWeb


EIDELBERG, Germany--German bioinformatics company Lion Bioscience, which revealed recently that it is planning a mid-year initial public offering on the Nasdaq and German NeuerMarkt exchanges, has formed a functional genomics partnership with Paradigm Genetics of Raleigh, North Carolina.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.